Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony T Newall

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Vaccine|July 14, 2026
The cost of respiratory syncytial virus (RSV) across all ages to the Australian healthcare systemKishor K Paul, Anthony T Newall
Vaccine|October 23, 2008
Influenza-related disease: the cost to the Australian healthcare systemAnthony T Newall, Paul A Scuffham
Vaccine|February 4, 2014
The cost-effectiveness of influenza vaccination in elderly Australians: an exploratory analysis of the vaccine efficacy requiredAnthony T Newall, Juan Pablo Dehollain
Pharmacoeconomics|July 14, 2012
Economic evaluations of childhood influenza vaccination: a critical reviewAnthony T Newall, Mark Jit, Philippe Beutels
Vaccine|May 10, 2016
Assessing the impact of vaccination programmes on burden of disease: Underlying complexities and statistical methodsNicole Mealing, Andrew Hayen, Anthony T Newall
Human Vaccines & Immunotherapeutics|January 30, 2013
Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategiesMark Jit, Anthony T Newall, Philippe Beutels
Expert Review of Pharmacoeconomics & Outcomes Research|April 17, 2014
Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccinationEmma Quinn, Mark Jit, Anthony T Newall
BMC Infectious Diseases|October 15, 2015
Review of economic evaluations of mask and respirator use for protection against respiratory infection transmissionShohini Mukerji, C Raina MacIntyre, Anthony T Newall
Pharmacoeconomics|June 25, 2015
Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for PracticeJames F O'Mahony, Anthony T Newall, Joost van Rosmalen
Vaccine|March 8, 2008
Influenza-related hospitalisation and death in Australians aged 50 years and olderAnthony T Newall, James G Wood, C Raina Macintyre
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Vaccine|July 14, 2026
The cost of respiratory syncytial virus (RSV) across all ages to the Australian healthcare systemKishor K Paul, Anthony T Newall
Vaccine|October 23, 2008
Influenza-related disease: the cost to the Australian healthcare systemAnthony T Newall, Paul A Scuffham
Vaccine|February 4, 2014
The cost-effectiveness of influenza vaccination in elderly Australians: an exploratory analysis of the vaccine efficacy requiredAnthony T Newall, Juan Pablo Dehollain
Pharmacoeconomics|July 14, 2012
Economic evaluations of childhood influenza vaccination: a critical reviewAnthony T Newall, Mark Jit, Philippe Beutels
Vaccine|May 10, 2016
Assessing the impact of vaccination programmes on burden of disease: Underlying complexities and statistical methodsNicole Mealing, Andrew Hayen, Anthony T Newall
Human Vaccines & Immunotherapeutics|January 30, 2013
Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategiesMark Jit, Anthony T Newall, Philippe Beutels
Expert Review of Pharmacoeconomics & Outcomes Research|April 17, 2014
Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccinationEmma Quinn, Mark Jit, Anthony T Newall
BMC Infectious Diseases|October 15, 2015
Review of economic evaluations of mask and respirator use for protection against respiratory infection transmissionShohini Mukerji, C Raina MacIntyre, Anthony T Newall
Pharmacoeconomics|June 25, 2015
Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for PracticeJames F O'Mahony, Anthony T Newall, Joost van Rosmalen
Vaccine|March 8, 2008
Influenza-related hospitalisation and death in Australians aged 50 years and olderAnthony T Newall, James G Wood, C Raina Macintyre
Pageof 7